Grupo Médico Camino S.C.

Mexico City, Mexico CITY (federal District) 3310

0 studies enrolling now · 2 studies all time

What they study most

Relapsing Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis

Studies at this site

• A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) — Running, not enrolling
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed